Angiodynamics (ANGO) EBIAT (2016 - 2025)
Historic EBIAT for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.4 million.
- Angiodynamics' EBIAT rose 4086.42% to -$6.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$27.7 million, marking a year-over-year increase of 8766.92%. This contributed to the annual value of -$34.0 million for FY2025, which is 8156.05% up from last year.
- Per Angiodynamics' latest filing, its EBIAT stood at -$6.4 million for Q4 2025, which was up 4086.42% from -$10.9 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' EBIAT ranged from a high of $45.9 million in Q3 2023 and a low of -$187.7 million during Q1 2024
- Moreover, its 5-year median value for EBIAT was -$9.0 million (2022), whereas its average is -$16.9 million.
- In the last 5 years, Angiodynamics' EBIAT soared by 45284.53% in 2023 and then tumbled by 187929.36% in 2024.
- Quarter analysis of 5 years shows Angiodynamics' EBIAT stood at -$8.4 million in 2021, then fell by 1.62% to -$8.5 million in 2022, then plummeted by 242.3% to -$29.0 million in 2023, then soared by 63.03% to -$10.7 million in 2024, then surged by 40.86% to -$6.4 million in 2025.
- Its EBIAT was -$6.4 million in Q4 2025, compared to -$10.9 million in Q3 2025 and -$6.0 million in Q2 2025.